A Novel Combination of Biallelic Variants in the VARS2 Gene: A Severe Phenotype
DOI:
https://doi.org/10.20344/amp.23831Keywords:
Cardiomyopathy, Hypertrophic, Epilepsy, Mitochondrial Diseases, Valine-tRNA Ligase/geneticsAbstract
To our knowledge, only 29 individuals have been described in the literature with biallelic pathogenic variants in the valyl-tRNA synthetase 2 (VARS2) gene, responsible for changes in the mitochondrial respiratory chain complex. We report two siblings with a novel combination of biallelic variants in the VARS2 gene (c.1079C>T p.Ala360Val, likely pathogenic, and c.1258G>A p.Ala420Thr, likely pathogenic). Both presented early hypertrophic cardiomyopathy and lactic acidosis, with fatal outcomes within the first year of life. The first also presented severe fetal growth restriction and a ventricular septal defect; the second developed epilepsy, respiratory failure, and psychomotor delay. This genotype may be linked to a particularly severe cardiac phenotype. Our report broadens the clinical and genetic spectrum of VARS2-related mitochondrial disease, highlights the variability of phenotypic expression, and reinforces the importance of early molecular diagnosis in neonatal-onset cardiomyopathy. Genetic confirmation enables accurate genetic counselling and consideration of prenatal or preimplantation diagnosis in future pregnancies.
Downloads
References
Kušíková K, Feichtinger RG, Csillag B, Kalev OK, Weis S, Duba HC, et al. Case report and review of the literature: a new and a recurrent variant in the vars2 gene are associated with isolated lethal hypertrophic cardiomyopathy, hyperlactatemia, and pulmonary hypertension in early infancy. Front. Pediatr. 2021;9:660076. DOI: https://doi.org/10.3389/fped.2021.660076
Ma K, Xie M, He X, Liu G, Lu X, Peng Q, et al. A novel compound heterozygous mutation in VARS2 in a newborn with mitochondrial cardiomyopathy: a case report of a Chinese family. BMC Med Genet. 2018;19:1-8. DOI: https://doi.org/10.1186/s12881-018-0689-3
Pereira S, Adrião M, Sampaio M, Basto MA, Rodrigues E, Vilarinho L, et al. Mitochondrial encephalopathy: first portuguese report of a VARS2 causative variant. JIMD Rep. 2018;42:113-9. DOI: https://doi.org/10.1007/8904_2018_89
Chin HL, Goh DL, Wang FS, Tay SK, Heng CK, Donnini C, et al. A combination of two novel VARS2 variants causes a mitochondrial disorder associated with failure to thrive and pulmonary hypertension. J Mol Med. 2019;97:1557-66. DOI: https://doi.org/10.1007/s00109-019-01834-5
Friedman J, Smith DE, Issa MY, Stanley V, Wang R, Mendes MI, et al. Biallelic mutations in valyl-tRNA synthetase gene VARS are associated with a progressive neurodevelopmental epileptic encephalopathy. Nat Commun. 2019;10:707. DOI: https://doi.org/10.1038/s41467-018-07067-3
Diodato D, Melchionda L, Haack TB, Dallabona C, Baruffini E, Donnini C, et al. VARS2 and TARS2 mutations in patients with mitochondrial encephalomyopathies. Hum Mutat. 2014;35:983-9. DOI: https://doi.org/10.1002/humu.22590
Taylor RW, Pyle A, Griffin H, Blakely EL, Duff J, He L, et al. Use of whole exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiency. JAMA. 2014;312:68-77. DOI: https://doi.org/10.1001/jama.2014.7184
Bruni F, Di Meo I, Bellacchio E, Webb BD, McFarland R, Chrzanowska-Lightowlers Z, et al. Clinical, biochemical, and genetic features associated with VARS2-related mitochondrial disease. Hum Mutat. 2018;39:563-78. DOI: https://doi.org/10.1002/humu.23398
Ruzman L, Kolic I, Radic Nisevic J, Ruzic Barsic A, Skarpa Prpic I, Prpic I. A novel VARS2 gene variant in a patient with epileptic encephalopathy. Ups J Med Sci. 2019;124:273–7. DOI: https://doi.org/10.1080/03009734.2019.1670297
Constante AD, Abreu SM, Trigo C. Mitochondrial cardiomyopathy: a puzzle for the final diagnosis. Cardiol Young. 2024;34:1393-6. DOI: https://doi.org/10.1017/S1047951124025095
Begliuomini C, Magli G, Di Rocco M, Santorelli FM, Cassandrini D, Nesti C, et al. VARS2-linked mitochondrial encephalopathy: two case reports enlarging the clinical phenotype. BMC Med Genet. 2019; 20:1-6. DOI: https://doi.org/10.1186/s12881-019-0798-7
Ferreira SL, Ferreira ST, Silva PG, Estrada J, Virella D, Casimiro A, et al. A case report of vars2-related encephalocardiomyopathy: expanding the phenotype. 2023. [cited 2025 Aug 21]. Available from: https://anuariohde.com/index.php/component/k2/item/3090-a-case-report-of-vars2-related-encephalocardiomyopathy-expanding-the-phenotype.
Marquez J, Viviano S, Rahman F, Strohbehn SD, Allworth A, Perez N, et al. Novel variants in VARS2 demonstrate the phenotypic variability of a rare mitochondriopathy that responds to valine supplementation. J Inherit Metab Dis. 2025;48:e70053. DOI: https://doi.org/10.1002/jimd.70053
lsemari A, Al-Younes B, Goljan E, Jaroudi D, Binhumaid F, Meyer BF, et al. Recessive VARS2 mutation underlies a novel syndrome with epilepsy, mental retardation, short stature, growth hormone deficiency, and hypogonadism. Hum Genomics. 2017;11:1-7. DOI: https://doi.org/10.1186/s40246-017-0124-4
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
